Titlebook: ;

invoke

書目名稱Guide to Clinical Management of Idiopathic Pulmonary Fibrosis影響因子(影響力)




書目名稱Guide to Clinical Management of Idiopathic Pulmonary Fibrosis影響因子(影響力)學(xué)科排名




書目名稱Guide to Clinical Management of Idiopathic Pulmonary Fibrosis網(wǎng)絡(luò)公開度




書目名稱Guide to Clinical Management of Idiopathic Pulmonary Fibrosis網(wǎng)絡(luò)公開度學(xué)科排名




書目名稱Guide to Clinical Management of Idiopathic Pulmonary Fibrosis被引頻次




書目名稱Guide to Clinical Management of Idiopathic Pulmonary Fibrosis被引頻次學(xué)科排名




書目名稱Guide to Clinical Management of Idiopathic Pulmonary Fibrosis年度引用




書目名稱Guide to Clinical Management of Idiopathic Pulmonary Fibrosis年度引用學(xué)科排名




書目名稱Guide to Clinical Management of Idiopathic Pulmonary Fibrosis讀者反饋




書目名稱Guide to Clinical Management of Idiopathic Pulmonary Fibrosis讀者反饋學(xué)科排名

Foam-Cells

Diseases that Mimic Idiopathic Pulmonary Fibrosis,There are number of conditions that may commonly be confused and difficult to differentiate from idiopathic pulmonary fibrosis (IPF). This chapter discusses these conditions in more detail.

Arthropathy

Badger

無(wú)意

https://doi.org/10.1007/978-3-642-28708-4. There are two agents that have been shown to slow the rate of deterioration in lung function in IPF. These two drugs, pirfenidone and nintedanib, have been variably approved in countries around the world.

Spina-Bifida

Spina-Bifida

極少

Treatment of Idiopathic Pulmonary Fibrosis,. There are two agents that have been shown to slow the rate of deterioration in lung function in IPF. These two drugs, pirfenidone and nintedanib, have been variably approved in countries around the world.

無(wú)聊的人

鑒賞家

Clinical Presentation and Diagnosis,are more likely to notice the onset of their symptoms sooner compared to those patients who are more sedentary. Given the non-specific symptoms of idiopathic pulmonary fibrosis (IPF), patients are frequently misdiagnosed initially. Non-specific symptoms include: